A patent was issued for the logo in 1911, over the years it has taken on many variations and Harley has also used many other designs. But the Bar & Shield, in orange, black and white remains its most ...
– Topline data from the first Phase 3 FOS study anticipated in H2 2025 representing major milestone in support of NDA filing and potential launch of azetukalner – First of three planned Phase ...
NewAmsterdam Pharma (NAMS) Company provided an update on the obicetrapib clinical development program and outlined its strategic priorities for 2025. NewAmsterdam is developing obicetrapib, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback